Pacer Advisors’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5K Buy
+1,373
New +$5.01K ﹤0.01% 2401
2024
Q3
– Sell
-786
Closed -$5.45K – 2637
2024
Q2
$5.45K Sell
786
-558
-42% -$3.92K ﹤0.01% 3629
2024
Q1
$10.3K Buy
+1,344
New +$10.8K ﹤0.01% 3530
2018
Q4
– Sell
-48,068
Closed -$297K – 843
2018
Q3
$297K Buy
48,068
+40,467
+532% +$183K 0.01% 955
2018
Q2
$49K Buy
7,601
+4,704
+162% +$33.5K ﹤0.01% 1116
2018
Q1
$20K Sell
2,897
-753
-21% -$8.77K ﹤0.01% 1014
2017
Q4
$46K Buy
+3,650
New +$44.5K ﹤0.01% 1025

Other funds holding MDXG

Pacer Advisors's MDXG Position: Q2 2026 in Review

Pacer Advisors opened a new position in MiMedx Group (MDXG) in Q2 2026: 1,373 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #2401 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in MDXG as recently as Q2 2024.

Pacer Advisors first reported a position in MDXG in Q4 2017 and has held it in 7 quarters since. The position peaked at $297K in Q3 2018. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Pacer Advisors held 1,373 shares of MiMedx Group worth $5K as of Q2 2026.
  • MiMedx Group was a new Pacer Advisors position in Q2 2026.
  • MiMedx Group made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2401 holding.
  • Pacer Advisors first reported a position in MiMedx Group in Q4 2017 and has held it in 7 quarters since.
  • Pacer Advisors's MiMedx Group position peaked at $297K in Q3 2018.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.